Analysis of cellular immune disturbances in COVID-19 for therapeutic stratification and prediction of long-term immunity.

  • Funded by Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)
  • Total publications:4 publications

Grant number: 01KI20161

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2021
  • Known Financial Commitments (USD)

    $268,958.64
  • Funder

    Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)
  • Principal Investigator

    Dr. Eva Schrezenmeier
  • Research Location

    Germany
  • Lead Research Institution

    Charité-Universitätsmedizin Berlin
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

discovery - This research project aims at expanding knowledge on human primary and secondary antigen-specific B lineage responses to a novel pathogen - severe acute respiratory syndrome corona virus-2 (SARS-CoV-2). We will study the characteristics of host-SARS-CoV-2 interaction with B lineage adaptive immunity including induction of anergy among different clinical courses of Corona Virus disease 2019 (COVID-19). The study will provide mechanistic evidence for novel treatment strategies currently adapted from rheumatology by comparing the immune response by COVID-19 infected individuals with those known from rheumatologic patients. We will further investigate long-term protective immunity after SARS-CoV-2 infection by analyzing serological and "steady state" antigen-specific B cells in the blood and bone marrow.

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Plasmablast-like Phenotype Among Antigen-Experienced CXCR5-CD19low B Cells in Systemic Lupus Erythematosus.

Altered increase in STAT1 expression and phosphorylation in severe COVID-19.

B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients.

Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients.